16 September 2026
G 1/25, Take Three: Anything You Leave in the Description May Be Used Against You
15 September 2026
Pay-for-delay: the CJEU confirms Teva/Cephalon and defines the limits of patent settlement agreements
14 September 2026
Valeo v. Bosch: the allocation of cases within the UPC, an alternative and not an exception
10 September 2026
The launch letter before the UPC: what generics and biosimilars should write to avoid creating urgency